October 14, 2026 Enliven Therapeutics Appoints Kristine Ball to Board of Directors Ahead of Planned Phase 3 Trial Initiation this Year
October 14, 2026 Riley Permian Increases Dividend and Schedules Third Quarter 2026 Earnings Release and Conference Call